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ABSTRACT
Aims: Lemierre syndrome is a life-threating condition characterized by recent oropharyngeal infection, internal jugular vein thrombosis, and 
anaerobic septicemia. It is usually caused by Fusobacterium necrophorum. 
Methods: A young Romanian male presented with fever and rigors, mild tachypnea, hypoxia, sore throat, decayed teeth, and tenderness 
of the left carotid triangle. Laboratory examination indicated severe sepsis with disseminated intravascular coagulation, acute renal 
failure, and acute respiratory distress syndrome while the Doppler ultrasonography of the carotids revealed left internal jugular venous 
thrombosis. The patient was administered piperacillin/tazobactam and vancomycin intravenously, doxycycline orally, and anti-coagulation 
by enoxaparin based on the diagnosis of Lemierre syndrome. Meanwhile, he was complicated by bilateral diffuse pulmonary cavities and 
encapsulated pleural effusions and so transcutaneous drainage was performed. The patient was discharged after a month and continued 
his treatment with oral phenoxypenicillin and doxycycline until full radiographic improvement. He was switched to oral anti-coagulation by 
vitamin-K antagonists and was referred to a hematologist, a vascular-surgeon, and a dentist.
Results: Streptococcus gordonii was isolated from the patient’s blood and pleural fluid cultures and serology for Rickettsial spp. IgM was 
positive. Thrombophilia genetic tests revealed three minor mutations for fibrinogen-455, plasminogen activator inhibitor-1, and 
methylenetetrahydrofolate reductase. According to the literature, S. gordonii is not usually a causative agent and Rickettsial spp. have as yet 
not been correlated with Lemierre syndrome. The failure of left jugular vein recanalization shows a possible causative role of the underlying 
thrombophilic predisposition. 
Discussion: Because of the syndrome’s rarity and the atypical microorganisms isolated in this case, increased awareness is advised for its 
diagnosis and the underlying mechanisms involved in its genesis. The role of anti-coagulation is debatable.
LEARNING POINTS
• Very rare condition. Medical practitioners should be vigilant in its diagnosis since septic jugular vein thrombophlebitis could be 
misdiagnosed as neck lymphadenitis.
• Duration of antibiotic therapy and additional anticoagulation treatment are still under discussion.
• Underlying thrombophilia predisposition should be excluded.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000606 European Journal of Case Reports in Internal Medicine © EFIM 2017
KEYWORDS
Septic thrombophlebitis, Lemierre, Rickettsia, thrombophilia, Streptococcus gordonii
CASE REPORT
A 23-year-old Romanian male with an unremarkable medical history was admitted after complaining about fever with rigors and a sore 
throat starting a week before he presented at the hospital. He was already being treated with antibiotics (amoxicillin/clavulanic acid). He 
recalled dust/soil exposure and a recent trip to Romania. He denied intake of alcohol and use of recreational drugs.
Physical examination revealed fever (temperature 38.1°) with rigors, tachycardia (148 bpm), signs of dehydration, and a mild 2/6 systolic 
murmur at the aortic valve position. Auscultation revealed mild crackles of the right middle and lower lobe. Tachypnea (20 breaths per 
minute) and hypoxia (SaO
2
: 89%) were also present. Other findings included herpes labialis, decayed teeth in the right lower mandible, 
tonsillitis without exudate, and a mildly tender neck lymphadenopathy of the left carotid triangle. 
Laboratory tests indicated an underlying infection causing severe sepsis and disseminated intravascular coagulation (DIC) (Table 1a). Air 
blood gases revealed hypoxia (PO
2
: 53.8 mmHg, SaO
2
: 87.7%) with mild elevation of lactic acid (1.3 mmol/L). Multiple insterstitial pulmonary 
infiltrates and signs of acute respiratory distress syndrome (ARDS) were shown on the chest radiograph (Figure 1a).
Table 1a. Laboratory examination of patient serum values during admission and after 36 days of hospitalization
Parameter Day 1 Day 36 Reference
White blood cells (WBCs) 26.01 9.52 x10^9/L 
(3.91-8.77)






Hemoglobin 14.5 11.5 g/dL (11.9-15.4)
Mean Cell Volume (MCV) 85.8 85.9 fL (77.0-93.0)
Mean Corpuscular 
Haemoglobin (MCH)
29.8 27.4 pg (27.0-32.0)
Reticulocytes % 0.2 4.2% % (0.039-0.057)





Fibrinogen 438.5 335.1 mg/dL 
(270.0-470.0)
D-Dimers 11499  ng/ml 
(0.0-550.0)
Glucose 91 169 mg/dL (74-106)
Parameter Day 1 Day 36 Reference
Urea 103 39 mg/dL (17-43)
Creatinine (Cr) 1.62 0.70 mg/dL (0.67-1.17)
Proteins 5.5 7.4 6.6-8.3 g/dL
Albumin 2.4 4.2 3.5-5.2 g/dL
Total Bilirubin 2.71 0.41 mg/dL (0.3-1.2)
Direct Bilirubin 1.22 -
Alkaline phosphatase (ALP) 413 90 IU/L (30-120)
Gamma-Glutamyltransferase
 (γ-GT)
134 21 IU/L (9-55)
Lactate degydrogenase
 (LDH)
684 399 IU/L (208-480)
C-reaction protein (CRP) 293.20 16.36 mg/L 
(0.00 - 5.00)
Procalcitonin (PCT) 5 Negative < 0.15 ng/ml
Antistreptolysin (ASTO) 32 - 10-200 IU/ml
Lupus anticoagulant Positive Negative
Lupus anticoagulant ratio 1.3 Negative 0.8-1.2
Parameter Day 1 Day 14 Day 60
R. typhi IgM 1/64 (positive) 1/256 (positive) 1/256
R. typhi IgG Negative Negative Negative
R. conorii IgM 1/64 (positive) 1/256 (positive) 1/128
R. conorii IgG Negative Negative Negative
Table 1b. Patient’s serological examination for Rickettsia spp. during admission and after 60 days of hospitalization
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He was administered a broad-spectrum antibiotic therapy with intravenous piperacillin-tazobactam 4.5 g four times daily, vancomycin 1 g 
twice daily, and 100 mg oral doxycycline twice daily with oxygen therapy, broncho-dilators, and chest physiotherapy. Fresh frozen plasma 
was also used for the treatment of DIC. 
The patient developed severe tachypnea, hemoptysis, epistaxis, and hypoxia on the second day of hospitalization. The chest x-ray showed 
multiple interstitial and nodular infiltrates with mild bilateral pleural effusions and multiple pulmonary cavities (Figure 1b). These findings 
were soon confirmed by an urgent computed tomography (CT) chest scan (Figure 1c). Transthoracic and transesophageal echocardiographs 
excluded infectious endocarditis. 
Further imaging with Doppler ultrasound (US) of the neck and later a CT-neck venography revealed mild neck lymphadenopathy and left 
internal jugular vein thrombosis with extension in the left anonymous vein (Figure 2a). So the diagnosis of complicated suppurative (septic) 
thrombophlebitis of the jugular vein or Lemierre syndrome (LS) was made. Low molecular weight heparin (LMWH) was administered in a 
therapeutic dose (enoxaparin 8000 IU twice daily subcutaneously) after consulting a vascular-surgeon specialist.
Blood and pleuritic fluid cultures tested positive for Streptococcus gordonii. In addition, rickettsial IgM antibodies were positive for Rickettsia 
typhi and Rickettsia conorii with 4-fold increase of their titer after two weeks (Table 1b). The antimicrobial therapy was then de-escalated to 
intravenous penicillin-G 6 million units four times daily and 100 mg oral doxycycline twice daily. 
Percutaneous thoracic drainage and a CT-guided transcutaneous catheter drainage were respectively performed (Figure 3a) 14 and 18 days 
after admission due to an increase of the left pleural fluid and the presence of an encapsulated fluid collection in serial chest radiographs. 
Repeating follow-up fluid culture after drainage was negative for any pathogen.
Further investigation by viral and immunological tests, influenza serology, urine and tonsil swab cultures, tuberculin skin test, streptococcus/
legionella urine antigen, and thrombophilia screening (protein C, protein S, antithrombin III, resistance to protein C) were normal. 
Lupus anticoagulant (LA) was positive (LA1/LA2 = 1.3, reference values 0.8 – 1.2), but it tested negative when repeated after six weeks. 
Figure 1: Chest radiograph on Day-1 (Figure 1a), chest radiograph (Figure 1b), and CT-
Chest scan (Figure 1c) on Day-3 of hospitalization showing radiographic deterioration 
with multiple patchy infiltrates, cavities, and mild pleural effusions. 
Figure 2: Patient’s CT-neck venography showing a mild neck lymphadenopathy and 
a left complete internal jugular vein thrombosis (red arrow) with extension in the left 
anonymous vein (Figure 2a) without any resolution of the thrombosis in the CT-neck 
venography at three month follow-up (Figure 2b).
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Genetic thrombophilia testing revealed three minor mutations with the patient being heterozygous for beta-fibrinogen-455, plasminogen 
activator inhibitor-1 (PAI-1 4G/5G), and Methylenetetrahydrofolate reductase (MTHFR C677T).
The patient was discharged after 36 days of hospitalization and after completing a month of intravenous penicillin-G and oral doxycycline. 
He was advised to continue oral antibiotic treatment with 500 mg phenoxypenicillin 4 times daily, and 100 mg doxycycline twice daily, and 
anticoagulation treatment with subcutaneous enoxaparine 8000 IU twice daily. The 3-month follow-up CT-chest scan showed complete 
resolution of the pulmonary cavities, infiltrates, and effusions (Figure 3b) and so the antimicrobial therapy was discontinued. On the contrary, 
the left jugular vein remained occluded in the follow-up CT-venography (Figure 2b) and the patient was referred to a hematologist while being 
prescribed oral anticoagulants with vitamin-K antagonists. He was also referred to a vascular surgeon for possible surgical reconstruction of 
the obstructed jugular vein and to a dentist for his decayed teeth which were considered as a possible primary infection site.
Figure 3. Patient’s CT-Chest scan after transcutaneous thoracic catheter and a drainage tube 
placement on Day-20 showing pulmonary cavities, an organized pleuritic fluid collection, and an 
iatrogenic pneumothorax (Figure 3a). The CT-Chest scan at 3 months follow-up with complete 
resolution of the effusions, cavities, and infiltrates of the lungs (Figure 3b)
DISCUSSION
Lemierre syndrome (LS) or “anaerobic postanginal sepsis” is a septic thrombophlebitis of the internal jugular vein with an incidence of one 
case in a million annually. After the medical advances leading to its early diagnosis and treatment, the syndrome’s mortality rate decreased 
from 90% to 15%. There are two categories of LS. The first occurs in young previously healthy people with recent upper respiratory or 
oral-pharyngeal infections. The second is developed in older adults with predisposition factors and portals of entry distal from the head i.e. 
central venous access devices, malignancies of the lung, colon, breast, and ovary in addition to thrombophilia[1].
Its main causative agent (81%) is Fusobacterium necrophorum while 11% are caused by other Fusobacterium spp. Other causative agents 
are MRSA, Klebsiella pneumoniae, Viridans streptococci group, Bacteroides fragilis, Peptostreptococcus spp., and Prevotella. Approximately one 
third of the patients may have poly-microbial bacteremia[2]. This case report describes an atypical complicated case of the syndrome in which 
Streptococcus gordonii and Rickettsiae were isolated and a minor genetic thrombophilic predisposition factors was also present. 
Diagnosis is facilitated after high clinical suspicion in patients with severe sepsis, ipsilateral neck tenderness parallel to the sternocleidomastoid 
muscle, and pulmonary compromise (with metastatic abscesses) after an acute pharyngotonsillar infection. The characteristic unilateral 
suppurative thrombophlebitis of the internal jugular vein is often misdiagnosed as cervical lymphadenitis. The differential diagnosis includes 
fever, rickettsial infections, endocarditis, tuberculosis, pneumonia, atypical pneumonia such as Legionnaire’s disease, and leptospirosis in 
patients with abnormal liver function tests. The diagnostic approach is thoroughly described in the case description[1].
In this case, blood and pleuritic fluid cultures isolated S. gordonii whereas the serological evaluation showed an increased titer of R. typhi and 
R. conorii IgM. Diagnosis was based on using GenBio IMMUNODOT semi-quantitative enzyme immunoassay for R. typhi and R. conorii as 
screening method and was confirmed using a Rickettsia IFA IgM/IgG antibody kit (with Indirect Fluorescence Immunoassay). 
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Confirmation PCR of the serum and the pleural fluid was not available at the hospital where the patient was hospitalised. It is interesting 
that an association between Rickettsiae and S. gordonii infection with LS has never been reported before. 
The patient’s poor oral hygiene may serve as the S. gordonii entry site to the bloodstream. On the other hand, the epidemiological history of 
the patient’s recent journey from Romania to Cyprus supported possible Rickettsia co-infection. According to the latest literature, R. conorii 
is one of the main pathogens of spotted fever in Romania[2]. The patient also presented a 4-fold increase of rickettsial antibodies titer in 
two sequential plasma samples taken 2 weeks apart, making the diagnosis of the infection definite[3]. There is no evidence in the current 
literature regarding a cross-reaction of Streptococcus spp. causing a false-positive Rickettsia IgM titer. How S. gordonii and R. conorii interacted 
resulting in LS in this case is not known. Consequently, more research is needed to elucidate the interaction between these two or any other 
microorganisms in the genesis of LS.
The patient was also screened for hereditary and acquired causes of thrombophilia revealing the minor mutations listed in the case 
description. There is little in the literature regarding genetically predisposition for developing LS from an oropharyngeal infection.
According to a review, a female patient with LS and genetic polymorphisms presented functional variations of Toll-like-5 receptor (TLR-
5) gene and two coagulation variations (Tissue Factor (TF) - 603 and Plasminogen-Activator-Inhibitor-1 (PAI-1) 4G-4G homozygous), 
which are frequently associated with thrombotic events. Another LS case revealed Prothrombin A20210G gene mutation, MTHFR gene 
polymorphism (C677T) mutation, and increased apolipoprotein levels with normal homocysteine levels[1-4]. Screening for an underlying 
malignancy or thrombophilia should be considered in some cases since an underlying hypercoagulable state may predispose to thrombosis 
in LS and may alter the type and duration of treatment[4].
The mainstay of LS treatment relies on a combination of broad-spectrum intravenous antibiotics directed against anaerobes, staphylococci, 
and streptococci (the treatment of choice is b-lactams/beta-lactamase inhibitor antibiotics with or without metronidazol or clindamycin). 
The optimal duration is uncertain but at least 2-4 weeks of intravenous antibiotics followed by another 2-4 weeks of oral antibiotics is 
advised. The patient may remain febrile for a prolonged period, which is probably explained by the endovascular nature of the infection 
and the frequent occurrence of metastatic necrotic abscesses. Surgical drainage of empyema and abscesses is often needed, and open 
thoracotomies and mediastinal exploration is required in cases of mediastinitis[1].
Furthermore, the literature describes a similar response to treatment with antibiotic and anticoagulation versus antibiotic therapy alone[5]. 
Most authors suggest treatment with heparin and antibiotics with discontinuation when acute illness resolves in order to avoid complications. 
Other researchers recommend anticoagulation in patients with significant clot burden (such as retrograde extension, bilateral neurological 
features due to endocranial thrombosis) and discontinuation when the infection is controlled and venous re-cannulation has been achieved[5]. 
To conclude, the authors of this article believe that anticoagulation in addition to antibiotic therapy is essential in patients with severe LS and 
extending thrombus, especially in cases with known thrombophilic disease or newly diagnosed thrombophilia predisposition. 
